Sex Reassignment Surgery Market Trends

  • Report ID: 6222
  • Published Date: Jun 19, 2024
  • Report Format: PDF, PPT

Sex Reassignment Surgery Market Trends

Growth Drivers

  • Increased government support - A sizable portion of the public should be encouraged to choose sex reassignment surgery via the implementation of new government laws that promote these procedures. According to the European Union Agency for Fundamental Rights, the minimum age for sex reassignment surgery is 16 in Malta and Ireland.

    Also, without establishing a minimum age threshold, Croatia permits minors to undergo sex reassignment surgery prior to turning 18 with parental permission. Therefore, growing support from the government is influencing the sex reassignment surgery market demand.
  • Increased awareness and acceptance of gender-affirming healthcare services - Gender-affirming healthcare treatments are seeing a notable upsurge in acceptability and support from the younger generations. This transformation in culture represents a positive step toward inclusivity and recognition of the special healthcare needs of transgender people.

    According to a survey by the World Economic Forum, there was a 24.6% increase in support for transgender rights among those who knew a transgender person. Policies and healthcare practices that prioritize gender-affirming care, such as access to Sex Reassignment Surgery (SRS) and related operations, are being pushed for by younger demographics more and more.
  • Growing advancements in sex reassignment surgeries - The sex reassignment surgery market forecast will be shaped by significant developments in sex reassignment surgery. For instance, the comprehensive transgender program at NYU Langone treats patients with gender dysphoria individually, focusing on their goals, circumstances, and co-occurring conditions.

    One of the few surgical programs in the US, vaginoplasty, or the reconstruction of the vagina, is a complicated technique that can be performed on qualifying transgender women using a robotic platform at NYU Langone. According to the study, most candidates for vaginoplasty can benefit from robotic surgery as an alternative to penile inversion. Patients with little genital skin can particularly benefit from robotic surgery.

Challenges

  • High costs of procedures - The sex reassignment surgery market demand may be negatively impacted by the high prices of these treatments. Surgery to convert a patient's gender from female to male, including a hysterectomy or phalloplasty, is typically costly and out of reach for most people. FTM surgery typically costs between USD 3,000 and USD 24,900, while more involved operations, such as phalloplasty, can have a higher price tag of USD 150,000.
  • Discrimination against transgenders - Many societies still stigmatize and discriminate against transgender people. It may lead to limited or delayed access to healthcare services that promote gender equality, such as sex reassignment surgery.

Sex Reassignment Surgery Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

11.7%

Base Year Market Size (2023)

USD 670.2 Million

Forecast Year Market Size (2036)

USD 3.1 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6222
  • Published Date: Jun 19, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of sex reassignment surgery was over USD 670.2 million.

The market size for sex reassignment surgery is projected to cross USD 3.1 billion by the end of 2036 expanding at a CAGR of 1 1.7% during the forecast period i.e., between 2024-2036.

The major players in the market are Bupa Group, Mayo Clinic, Amish Hospital, Boston Medical Center, Cleveland Clinic, Transgender Surgery Institute, Plastic Surgery Group of Rochester, The Johns Hopkins University, IM Gender Clinic, GRS Montreal Clinic, and others.

The female to male segment is anticipated to garner a CAGR of 12% during 2024-2036.

The Europe sex reassignment surgery sector is poised to garner a revenue of 500 million by the end of 2036.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample